Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

The Most Important Rules Not to Miss Facial Melanoma

Description

The presentation focuses on the critical rules for diagnosing facial melanoma using dermoscopy. The speaker emphasizes the increasing incidence of facial melanoma, particularly lentigo maligna, highlighting case studies that illustrate misdiagnoses and the necessity for accurate diagnosis. It is noted that many lesions appear benign under non-dermoscopic inspection, yet may actually be malignant, underscoring the importance of dermoscopy for correct identification. The speaker discusses the benignity and malignancy criteria based on the presence of specific patterns and features observed through dermoscopy, such as reticular lines and sharp demarcations associated with benign lesions, while irregular pigmentation and asymmetry may indicate malignancy. They stress the essential practice of biopsy for uncertain lesions, as early detection is key to improving patient outcomes. The session concludes with a reminder that knowing the characteristics of pigmented lesions can lead to better diagnostic accuracy, thereby saving lives.

View more

Conclusions

  • Accurate diagnosis of facial melanoma is crucial to avoid misdiagnosis and facilitate early intervention.
  • The incidence of melanoma is increasing, particularly in the elderly population, highlighting the need for improved detection methods.
  • Dermatologists should employ dermoscopy as a necessary tool for distinguishing melanoma from benign lesions such as solar lentigo and actinic keratosis.
  • Identifying benignity criteria, such as the presence of reticular lines and sharp demarcations, can help in assessing lesions as non-malignant.
  • Malignancy criteria, including asymmetrical pigmentation and the presence of homogeneous areas, are key indicators for diagnosing melanoma.
  • Lesions showing focal malignant criteria should always be biopsied to confirm diagnosis and ensure timely treatment.
  • Education on recognizing both benignity and malignancy features is essential for dermatologists to enhance their diagnostic accuracy.
  • Philipp TSCHANDL1, Alessio GAMBARDELLA2, Amélie BOESPFLUG3, Teresa DEINLEIN4, Vincenzo DE GIORGI5, Harald KITTLER1, Aimilios LALLAS6, Josep MALVEHY7, Elvira MOSCARELLA8, Susana PUIG7, Massimiliano SCALVENZI9, Luc THOMAS3, Iris ZALAUDEK4, Roberto ALFANO10 and Giuseppe ARGENZIANO2